Robert M. Clancy

8.8k total citations · 1 hit paper
117 papers, 5.3k citations indexed

About

Robert M. Clancy is a scholar working on Rheumatology, Immunology and Immunology and Allergy. According to data from OpenAlex, Robert M. Clancy has authored 117 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Rheumatology, 60 papers in Immunology and 33 papers in Immunology and Allergy. Recurrent topics in Robert M. Clancy's work include Systemic Lupus Erythematosus Research (58 papers), Cell Adhesion Molecules Research (32 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Robert M. Clancy is often cited by papers focused on Systemic Lupus Erythematosus Research (58 papers), Cell Adhesion Molecules Research (32 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Robert M. Clancy collaborates with scholars based in United States, Australia and France. Robert M. Clancy's co-authors include Jill P. Buyon, Steven B. Abramson, J Leszczynska-Piziak, Deborah Friedman, Peter Izmirly, David Levartovsky, Bruce K. Young, Tony E. Hugli, Anca Askanase and John Rediske and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Robert M. Clancy

115 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase.

1992 591 citations Robert M. Clancy, Steven B. Abramson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert M. Clancy United States	40	1.9k	1.8k	1.3k	976	923	117	5.3k
Fujío Numano Japan	43	1.2k 0.7×	1.3k 0.7×	600 0.5×	797 0.8×	959 1.0×	230	6.1k
Yoshihisa Nojima Japan	40	509 0.3×	1.6k 0.9×	428 0.3×	2.2k 2.2×	352 0.4×	231	6.1k
Hans J. Baelde Netherlands	41	538 0.3×	1.1k 0.6×	737 0.6×	1.8k 1.9×	323 0.3×	160	5.8k
Jo H. M. Berden Netherlands	54	2.6k 1.4×	2.8k 1.5×	391 0.3×	2.1k 2.2×	313 0.3×	176	7.8k
Emile de Heer Netherlands	47	516 0.3×	1.3k 0.7×	851 0.7×	2.9k 2.9×	451 0.5×	204	8.5k
Bruno Esposito France	38	518 0.3×	4.5k 2.5×	873 0.7×	2.3k 2.4×	1000 1.1×	72	8.0k
Katsuo Sueishi Japan	47	461 0.2×	809 0.4×	622 0.5×	2.7k 2.7×	1.2k 1.3×	203	7.5k
Peter W. Mathieson United Kingdom	53	534 0.3×	1.9k 1.0×	795 0.6×	3.1k 3.2×	464 0.5×	178	9.4k
Donald B. Bloch United States	42	1.1k 0.6×	601 0.3×	1.1k 0.9×	2.3k 2.3×	637 0.7×	120	5.8k
Mark B. Taubman United States	56	389 0.2×	1.9k 1.0×	649 0.5×	3.1k 3.2×	1.9k 2.0×	115	9.1k

Countries citing papers authored by Robert M. Clancy

Since Specialization

Citations

This map shows the geographic impact of Robert M. Clancy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Clancy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Clancy more than expected).

Fields of papers citing papers by Robert M. Clancy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Clancy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Clancy. The network helps show where Robert M. Clancy may publish in the future.

Co-authorship network of co-authors of Robert M. Clancy

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Clancy. A scholar is included among the top collaborators of Robert M. Clancy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Clancy. Robert M. Clancy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khalili, Leila, Wei Tang, Yevgeniya Gartshteyn, et al.. (2025). CAR T-cell therapy in SLE: A systematic review. Seminars in Arthritis and Rheumatism. 74. 152786–152786. 2 indexed citations

Cornwell, MacIntosh, Hanane El Bannoudi, Tessa J. Barrett, et al.. (2023). Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype. Journal of Translational Medicine. 21(1). 247–247. 15 indexed citations

Kaizer, Alexander, Robert M. Clancy, Anne E. Tebo, et al.. (2022). Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro/SSA antibody titers. American Journal of Obstetrics and Gynecology. 227(5). 761.e1–761.e10. 7 indexed citations

Iwamoto, Taro, Jessica M. Dorschner, Shanmugapriya Selvaraj, et al.. (2021). High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis. The Journal of Rheumatology. 49(4). 388–397. 25 indexed citations

Friedman, Deborah, Mimi Kim, N. Costedoat‐Chalumeau, et al.. (2020). Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation. Circulation Arrhythmia and Electrophysiology. 13(10). e008686–e008686. 20 indexed citations

Izmirly, Peter, Mimi Kim, Deborah Friedman, et al.. (2020). Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. Journal of the American College of Cardiology. 76(3). 292–302. 101 indexed citations

Katz, Grégory, Nathaniel R. Smilowitz, Ashira Blazer, et al.. (2019). Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients. Mayo Clinic Proceedings. 94(8). 1436–1443. 39 indexed citations

Grönwall, Caroline, Robert M. Clancy, Katy A. Lloyd, et al.. (2016). Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity. Journal of Autoimmunity. 73. 30–41. 7 indexed citations

Saxena, Amit, Peter Izmirly, Sung Won Han, et al.. (2015). Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus. Journal of the American College of Cardiology. 66(8). 930–939. 25 indexed citations

10.

Ramos, Paula S., et al.. (2012). Brief Report: Enrichment of associations in genes with fibrosis, apoptosis, and innate immunity functions with cardiac manifestations of neonatal lupus. Arthritis & Rheumatism. 64(12). 4060–4065. 12 indexed citations

11.

Clancy, Robert M., David Álvarez, Elena V. Komissarova, et al.. (2010). Ro60-Associated Single-Stranded RNA Links Inflammation with Fetal Cardiac Fibrosis via Ligation of TLRs: A Novel Pathway to Autoimmune-Associated Heart Block. The Journal of Immunology. 184(4). 2148–2155. 75 indexed citations

12.

Buyon, Jill P., Robert M. Clancy, & Deborah Friedman. (2009). Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nature Reviews Rheumatology. 5(3). 139–148. 65 indexed citations

13.

Izmirly, Peter, Laura Barisoni, Jill P. Buyon, et al.. (2008). Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis. Lara D. Veeken. 48(5). 513–519. 20 indexed citations

14.

Rivera, Tania L., Peter Izmirly, Paula Byrne, et al.. (2008). Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Annals of the Rheumatic Diseases. 68(6). 828–835. 66 indexed citations

15.

Neufing, Petra J., Robert M. Clancy, Michael Jackson, et al.. (2005). Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells. Arthritis & Rheumatism. 52(12). 3934–3942. 23 indexed citations

16.

Clancy, Robert M., Raj P. Kapur, Yair Molad, Anca Askanase, & Jill P. Buyon. (2004). Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis & Rheumatism. 50(1). 173–182. 157 indexed citations

17.

Clancy, Robert M., Chelsea B. Backer, Xiao‐Ming Yin, et al.. (2003). Cytokine Polymorphisms and Histologic Expression in Autopsy Studies: Contribution of TNF-α and TGF-β1 to the Pathogenesis of Autoimmune-Associated Congenital Heart Block. The Journal of Immunology. 171(6). 3253–3261. 77 indexed citations

18.

Amin, Ashok R., Mukundan Attur, Mandar Dave, et al.. (2001). Functional genomic analysis in arthritis-affected cartilage Yin-yang regulation of inflammatory mediators by alpha5beta1 and alphavbeta3. The FASEB Journal. 15(4). 3397. 2 indexed citations

19.

Miranda‐Carús, María‐Eugenia, Anca Askanase, Robert M. Clancy, et al.. (2000). Anti-SSA/Ro and Anti-SSB/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-α by Macrophages. The Journal of Immunology. 165(9). 5345–5351. 143 indexed citations

20.

Clancy, Robert M., et al.. (2000). Nitric Oxide Synthase/COX Cross-Talk: Nitric Oxide Activates COX-1 But Inhibits COX-2-Derived Prostaglandin Production. The Journal of Immunology. 165(3). 1582–1587. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact